share_log

北海康成-B:內幕消息用於治療膠質母細胞瘤的CAN008 II期臨床試驗結果

CANBRIDGE-B: INSIDE INFORMATION RESULTS OF CAN008 PHASE II CLINICAL TRIAL FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

Hong Kong Stock Exchange ·  Apr 22 22:50

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.